BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 19068380)

  • 1. Hydroxyapatite orbital implants.
    Oestreicher JH
    Ophthalmology; 2008 Nov; 115(11):2096; author reply 2096-7. PubMed ID: 19068380
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydroxyapatite implants.
    Jordan DR
    Ophthalmology; 2008 Dec; 115(12):2320-1; author reply 2321. PubMed ID: 19041493
    [No Abstract]   [Full Text] [Related]  

  • 3. Exposure rate of hydroxyapatite orbital implants a 15-year experience of 802 cases.
    Yoon JS; Lew H; Kim SJ; Lee SY
    Ophthalmology; 2008 Mar; 115(3):566-572.e2. PubMed ID: 17854900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary placement of a hydroxyapatite-coated sleeve in bioceramic orbital implants.
    Liao SL; Shih MJ; Lin LL
    Am J Ophthalmol; 2005 Feb; 139(2):235-41. PubMed ID: 15733982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary placement of hydroxyapatite-coated sleeves in bioceramic orbital implants.
    Jordan DR
    Am J Ophthalmol; 2005 Feb; 139(2):333-4. PubMed ID: 15733997
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of exposure of porous orbital implants following enucleation.
    Naik MN; Mittal R; Murthy RK; Honavar SG
    Am J Ophthalmol; 2007 Jul; 144(1):161-2; author reply 162. PubMed ID: 17601454
    [No Abstract]   [Full Text] [Related]  

  • 7. Hydroxyapatite implants.
    Perry JD
    Ophthalmology; 2003 Jul; 110(7):1281; author reply 1281. PubMed ID: 12867364
    [No Abstract]   [Full Text] [Related]  

  • 8. Evisceration vs. enucleation.
    Goisis M; Guareschi M; Miglior S; Giannì AB
    Ophthalmology; 2007 Oct; 114(10):1960; author reply 1959-60. PubMed ID: 17908612
    [No Abstract]   [Full Text] [Related]  

  • 9. Evisceration vs. enucleation.
    Bernardino CR
    Ophthalmology; 2007 Oct; 114(10):1959; author reply 1959-60. PubMed ID: 17908611
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary placement of a titanium sleeve in hydroxyapatite orbital implants.
    Liao SL; Chen MS; Lin LL
    Eye (Lond); 2005 Apr; 19(4):400-5. PubMed ID: 15297860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Explanted polyethylene implants.
    Sandramouli S; Tambe K; Pushpoth S; Mudhar H
    Ophthalmology; 2010 Jan; 117(1):194-5; author reply 195. PubMed ID: 20114114
    [No Abstract]   [Full Text] [Related]  

  • 12. A new technique with the hydroxyapatite implant.
    Suvağ N; Katircioğlu Y; Duman S
    Jpn J Ophthalmol; 2004; 48(2):179-80. PubMed ID: 15060803
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: "porous implant exposure: incidence, management, and morbidity".
    Jordan DR; Munger R
    Ophthalmic Plast Reconstr Surg; 2007; 23(6):505-6; author reply 506. PubMed ID: 18030146
    [No Abstract]   [Full Text] [Related]  

  • 14. Scleral wrap increases the long-term complication risk of bone-derived hydroxyapatite orbital implants.
    Toh T; Bevin TH; Molteno AC
    Clin Exp Ophthalmol; 2008 Nov; 36(8):756-61. PubMed ID: 19128381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative rotation of hydroxyapatite enucleation implants.
    Custer PL
    Arch Ophthalmol; 1999 Nov; 117(11):1521-3. PubMed ID: 10565521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of exposure of porous orbital implants following enucleation.
    Wang JK; Liao SL; Lai PC; Lin LL
    Am J Ophthalmol; 2007 Jan; 143(1):61-67. PubMed ID: 17109809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late exposure of the bioceramic orbital implant.
    Wang JK; Lai PC; Liao SL
    Am J Ophthalmol; 2009 Jan; 147(1):162-170.e1. PubMed ID: 18571617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with the polymer-coated hydroxyapatite implant after enucleation in 126 patients.
    Shields CL; Uysal Y; Marr BP; Lally SE; Rodriques E; Kharod B; Shields JA
    Ophthalmology; 2007 Feb; 114(2):367-73. PubMed ID: 17270685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bovine pericardium (Tutopatch) wrap for hydroxyapatite implants.
    Gupta M; Lyon F; Singh AD; Rundle PA; Rennie IG
    Eye (Lond); 2007 Apr; 21(4):476-9. PubMed ID: 16440021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Porous orbital implants, wraps, and PEG placement in the pediatric population after enucleation.
    Wang JK; Liao SL; Lin LL; Kao SC; Tseng HS
    Am J Ophthalmol; 2007 Jul; 144(1):109-116. PubMed ID: 17499206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.